NCT05063786
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05063786 |
| Title | Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET) (ALPHABET) |
| Acronym | ALPHABET |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | Yes |
| Sponsors | Spanish Breast Cancer Research Group |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | NLD | ITA | FRA | ESP | CHE | AUT |
CKB BOOST